IKS Health Acquires Arai Solutions for INR 11 Crores to Boost AI Stack
Inventurus Knowledge Solutions Limited's IKS Health announced the acquisition of 100% share capital in Arai Solutions Private Limited for INR 11,00,00,000 on May 13, 2026, to be completed by June 20, 2026. Arai Solutions, incorporated on April 5, 2024, reported FY 2025-26 revenue of INR 5,462,600 and net worth of INR 956,433. The deal aims to enhance IKS Health's full-stack AI architecture with biomedical knowledge graphs and accelerate AI R&D across clinical and operational workflows.
*this image is generated using AI for illustrative purposes only.
Inventurus Knowledge Solutions Limited's healthcare brand, IKS Health, announced the acquisition of 100% of the share capital in Arai Solutions Private Limited for a total cash consideration of INR 11,00,00,000 (Indian Rupees Eleven Crores only) on May 13, 2026. The Board of Directors approved the transaction at its meeting held on the same date, with the acquisition expected to be completed by or before June 20, 2026. The announcement was made via a press release filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with BSE Limited and the National Stock Exchange of India Limited. Upon completion, Arai Solutions Private Limited will become a wholly-owned subsidiary of Inventurus Knowledge Solutions Limited.
About the Acquired Entity
Arai Solutions Private Limited (CIN: U58200KA2024PTC187134) is a private limited company incorporated on April 5, 2024, under the laws of India, with its registered office at D-37, Golden Enclave, Airport Road, Vimanapura, Bangalore, Karnataka, 560017, India. The company operates in the Information Technology Enabled Services (ITeS) industry and is engaged in providing consultancy services related to artificial intelligence solutions across industries, including the healthcare space. Its specific areas of expertise include research and development in algorithms and architectures, deep learning, machine learning, generative AI, large language models, natural language processing, symbolic AI (including knowledge graphs and logic systems), hybrid AI solutions, AI for cybersecurity, and neural networks with hardware acceleration. The acquisition does not constitute a related party transaction, and the Promoter/Promoter Group of Inventurus Knowledge Solutions Limited has no interest in the entity being acquired.
Financial Profile of Arai Solutions
The following table presents the financial details of Arai Solutions Private Limited for FY 2025-26, as disclosed in the regulatory filing:
| Particulars: | FY 2025-26 (Amt in INR) |
|---|---|
| Revenue from Operations: | 5,462,600 |
| Other Income: | 75,794 |
| Total Income: | 5,538,394 |
| Net Worth: | 956,433 |
The revenue history of the target over the last three years is as follows:
| Year: | Revenue (in INR) |
|---|---|
| 2025-26: | 5,462,600 |
| 2024-25: | 550,555 |
| 2023-24: | Not applicable (incorporated on April 5, 2024) |
Key Acquisition Details
The principal terms of the acquisition as disclosed under Regulation 30 are summarised below:
| Parameter: | Details |
|---|---|
| Acquirer: | IKS Health (Inventurus Knowledge Solutions Limited) |
| Acquired Entity: | Arai Solutions Private Limited |
| Announcement Date: | May 13, 2026 |
| Consideration Type: | Cash |
| Total Consideration: | INR 11,00,00,000 (Indian Rupees Eleven Crores only) |
| Shares Acquired: | 10,000 equity shares of INR 10/- each (100% of paid-up share capital) |
| Post-Acquisition Status: | Wholly-owned subsidiary |
| Expected Completion: | By or before June 20, 2026 |
| Regulatory Approvals: | Not applicable |
| Filing Regulation: | Regulation 30, SEBI LODR Regulations |
Strategic Rationale
IKS Health currently possesses a four-layer healthcare AI stack encompassing EMR integration, platform orchestration, trust/compliance, and AI applications. ARAI's ontology introduces a critical knowledge layer to this existing framework, which the company states makes IKS Health the only full-stack player with proprietary domain intelligence at every level. ARAI's interconnected biomedical knowledge graphs, grounded in peer-reviewed research, feed a central reasoning engine that is directly mappable to IKS Health platform outputs. The acquisition is designed to accelerate the development of a full agentic AI technology stack, with capabilities to create a more efficient proprietary small language model, and is expected to enhance IKS Health's existing care management workflows and accelerate the company's AI R&D.
The following key areas are expected to benefit from accelerated platform development and reduced dependency on third-party AI infrastructure:
- Autonomous coding
- Clinical decisions
- Denial prevention
- Prior authorization reasoning
- Precision medicine
Leadership Perspectives
Sachin K. Gupta, Founder and Global CEO of IKS Health, stated that ARAI's clinical knowledge infrastructure makes IKS Health AI operational models "even more economical, reliable, auditable, and capable of reasoning." He added that uniting ARAI with IKS Health adds a "valuable and complementary layer" to the platform as the company scales its AI-driven and human-in-the-loop approach in line with evolving clinical and regulatory guidelines. Dr. Roland Haas, co-founder and CEO of ARAI, noted that IKS Health is positioned to disrupt the health tech industry by creating AI-driven systems of action, and expressed that ARAI is pleased to join forces as IKS Health extends into next-generation clinical and operational AI models. Dr. Asoke Talukder, co-founder and CAIO of ARAI, highlighted that ARAI's framework fills the critical AI infrastructure knowledge layer, reinforcing IKS Health's position as the only full-stack player with proprietary domain intelligence at every tier.
A key differentiator highlighted in the announcement is ARAI's explainable AI approach, which the company describes as converting "black box AI into glass box AI," enabling predictions that are transparent, explainable, and traceable. IKS Health was founded in 2006 and has been recognised by Black Book as the top provider of AI-driven RCM services, by KLAS for performance and client satisfaction, and by Google Cloud with a DORA Award for "Augmenting Human Expertise with AI."
Historical Stock Returns for Inventurus Knowledge Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.07% | +0.50% | +10.56% | +3.57% | +0.89% | -14.63% |
How will IKS Health's proprietary small language model, enabled by ARAI's knowledge graphs, compete against established healthcare AI players like Microsoft Nuance or Google Health in terms of clinical accuracy and cost efficiency?
Could IKS Health's 'full-stack' AI positioning accelerate its pursuit of additional acquisitions targeting gaps in autonomous coding or prior authorization reasoning capabilities?
Given ARAI's rapid revenue growth from INR 5.5 lakh to INR 54.6 lakh in a single year, what revenue contribution milestones is IKS Health targeting from this subsidiary over the next two to three fiscal years?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
